Aromatase inhibitor (unspecified)
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Aromatase inhibitor (unspecified), covering 2013-12-20 to 2025-09-29. Get the full timeline:
Most recent: Clinical Trial Update: MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) [Phase 3]